Loading organizations...

§ Private Profile · Austin, TX, USA
Conversational AI platform for healthcare patient communications, automating voice, text, and chat for providers.
Hello Patient, an Austin, Texas-based company, develops conversational AI to automate end-to-end patient communications for healthcare providers, aiming to reduce administrative burdens and improve patient access. The platform handles voice, text, and chat, targeting issues like inefficient scheduling and eligibility workflows with specialized healthcare expertise. In September 2025, the company secured $22.5 million in Series A funding, led by Scale Venture Partners, achieving a $100 million valuation. Its SaaS platform has powered over 100,000 phone calls and 300,000 patient conversations within its first year, serving outpatient healthcare providers such as Revive Med Spa and digital health companies like Octave Health. Additional investors include 8VC, Bling Capital, Max Ventures, and Remus Capital. Hello Patient was founded in 2024 by Alex Cohen.
Hello Patient has raised $29.0M across 2 funding rounds.
Hello Patient has raised $29.0M in total across 2 funding rounds.
Hello Patient has raised $29.0M across 2 funding rounds. Most recently, it raised $23.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2025 | $23M Series A | Scale Venture Partners | 8VC, Alumni Ventures, Coughdrop Capital, Flex Capital, Harlem Capital, Innovation Endeavors, MAX Ventures, Next Play Ventures, Andrew Berman, Julius Genachowski, Russell Fradin, Russ Fradin, 8VC, Bling Capital, Firstlook Partners, Remus Capital | Announced |
| Oct 1, 2024 | $6M Seed | — | 8VC, Acrew Capital, AirAngels, Alumni Ventures, Amplify Partners, Coughdrop Capital, Fifty Years, FirstMark Capital, Flex Capital, G20 Ventures, Kearny Jackson, MAX Ventures, NextView Ventures, Preston Werner Ventures, Scale Venture Partners, Silicon Valley Connect, Adam Lisagor, Andrew Berman, Chris Schaepe, Russell Fradin, Russ Fradin | Announced |
# Hello Patient: High-Level Overview
Hello Patient is a conversational AI platform that automates end-to-end patient communications for healthcare practices.[1] The company addresses a critical operational bottleneck in outpatient healthcare: the gap between expensive patient acquisition efforts and the reality of overwhelmed front-desk staff who struggle to convert inbound leads, schedule appointments, and re-engage patients.[4] By deploying AI agents that handle voice calls, text messages, and chat across 24/7 operations, Hello Patient helps practices reduce administrative burden, improve patient retention, and free clinical staff to focus on direct care.
The company serves outpatient healthcare groups ranging from specialized clinics like Revive Med Spa to national digital health platforms like Octave Health.[1] In less than a year since launch, Hello Patient has powered over 100,000 phone calls and 300,000 patient conversations, demonstrating strong early market validation.[1] The platform delivers measurable outcomes: 100% call answer rates (25% higher than typical front desks), 18% more appointments booked (averaging 3 additional appointments per location daily), and 95% reduction in patient wait times.[3]
# Origin Story
Hello Patient was founded by Alex Cohen, who previously led consumer product and growth at Carbon Health, a digital health company focused on patient acquisition and retention.[4] Cohen's founding insight emerged from a frustrating realization: four years before launching Hello Patient, he attempted to automate patient calls and texts using traditional call center software—an approach that fundamentally misunderstood healthcare's unique requirements.[1] This experience revealed that "patient engagement" isn't simply about getting patients in the door; it's about orchestrating every touchpoint from initial inquiry through appointment booking to billing and follow-up care.[4]
The company launched with a team bringing 25+ combined years of healthcare experience across specialties including women's health, primary care, occupational medicine, and metabolic health.[5] This healthcare-native founding team distinguished Hello Patient from generic conversational AI vendors lacking domain expertise. The company achieved rapid early traction, which attracted a $22.5 million Series A in late 2025 led by Scale Venture Partners, with participation from 8VC, Bling Capital, Max Ventures, Remus Capital, and FirstLook Partners.[1]
# Core Differentiators
# Role in the Broader Tech Landscape
Hello Patient operates at the intersection of three powerful trends reshaping healthcare: AI-driven automation of administrative work, the shift toward patient-centric digital health, and the operational crisis facing outpatient practices.
Healthcare practices face a structural problem: they spend heavily on patient acquisition marketing but lack technology to convert those leads efficiently. Front-desk staff—often paid $20/hour—become the bottleneck between expensive marketing spend and actual patient conversion.[4] This creates a "high CAC, low retention" business model that Hello Patient directly addresses. As healthcare organizations increasingly adopt digital-first strategies and face persistent staffing shortages, conversational AI that handles routine communications becomes essential infrastructure rather than a nice-to-have feature.
The timing is particularly favorable. Generative AI has matured enough to handle nuanced healthcare conversations while meeting regulatory requirements, and healthcare practices are actively seeking solutions to operational inefficiency. Hello Patient's early success—100,000+ calls in under a year—suggests the market is ready for this category. The company is essentially defining a new category: healthcare-native patient engagement AI, distinct from both generic conversational AI platforms and legacy patient management software.
By solving the "front door" problem in healthcare, Hello Patient influences the broader ecosystem by demonstrating that AI can improve both operational efficiency and patient experience simultaneously—a rare combination that validates AI's role in healthcare beyond clinical diagnostics.
# Quick Take & Future Outlook
Hello Patient is positioned to become the category-defining patient engagement platform for outpatient healthcare.[4] With $22.5 million in Series A funding and proven early traction, the company's immediate focus will be scaling to healthcare organizations nationwide while expanding product capabilities—likely including deeper integrations with electronic health records (EHRs) and practice management systems.
The company's trajectory will be shaped by several factors: consolidation in healthcare IT (as larger EHR and practice management vendors acquire or partner with specialized AI tools), regulatory evolution around AI in healthcare, and competitive pressure from both healthcare incumbents and well-funded AI startups entering the space. Hello Patient's healthcare-native founding team and early customer success provide defensibility, but the market opportunity is large enough that competition will intensify.
The broader implication: as AI matures, healthcare's competitive advantage will increasingly belong to organizations that embed AI into patient-facing workflows rather than treating it as a back-office tool. Hello Patient is betting—and early evidence suggests correctly—that the patient communication layer is where AI creates the most immediate, measurable value for healthcare practices.
Hello Patient has raised $29.0M in total across 2 funding rounds.
Hello Patient's investors include Scale Venture Partners, 8VC, Alumni Ventures, Coughdrop Capital, Flex Capital, Harlem Capital, Innovation Endeavors, Max Ventures, Next Play Ventures, Andrew Berman, Julius Genachowski, Russell Fradin.